Literature DB >> 15042510

MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.

Tsun Leung Chan1, Yee Wai Chan, Judy W C Ho, Celine Chan, Annie S Y Chan, Emily Chan, Polly W Y Lam, Chun Wah Tse, Kam Cheong Lee, Chi Waii Lau, Elaine Gwi, Suet Yi Leung, Siu Tsan Yuen.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) accounts for approximately 2% of all colorectal cancer (CRC) cases and is the most common hereditary CRC syndrome. We have previously reported a high incidence of microsatellite instability (MSI) and germline mismatch repair (MMR) gene mutations in young Hong Kong Chinese with CRC. Ongoing studies at the Hereditary Gastrointestinal Cancer Registry in Hong Kong have revealed a unique germline MSH2 c.1452-1455delAATG mutation that has not been reported in other ethnic groups. Detailed analysis showed that this specific MSH2 mutation constituted 21% of all germline MMR gene mutations and 36% of all MSH2 germline mutations identified. We designed a specific PCR-based diagnostic test on paraffin-embedded tissues and identified this germline mutation in 2 (1.5%) of 138 consecutive patients with early-onset CRC (<46 years of age at diagnosis). Haplotype analysis was performed using 11 microsatellite markers located between D2S391 and D2S123. All 10 families had the same disease haplotype, suggesting a founder effect. These 10 families all originated from the Chinese province of Guangdong, which historically included Hong Kong. It is the most populous of the Chinese provinces, with a population of >93 million. Further analysis suggested that this founder mutation may date back to between 22 and 103 generations ago. The identification of this MSH2 founder mutation has important implications for the design of mutation-detection strategies for the southern Chinese population. Since there were major emigrations from Hong Kong and Guangdong province during the 19th and 20th centuries, this finding is also significant for Chinese communities worldwide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042510      PMCID: PMC1181966          DOI: 10.1086/383591

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Age and origin of the FCMD 3'-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population.

Authors:  R Colombo; A A Bignamini; A Carobene; J Sasaki; M Tachikawa; K Kobayashi; T Toda
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

3.  Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.

Authors:  R Shiri-Sverdlov; P Oefner; L Green; R G Baruch; T Wagner; A Kruglikova; S Haitchick; R M Hofstra; M Z Papa; I Mulder; S Rizel; R B Bar Sade; E Dagan; Z Abdeen; B Goldman; E Friedman
Journal:  Hum Mutat       Date:  2000-12       Impact factor: 4.878

Review 4.  Deficient DNA mismatch repair: a common etiologic factor for colon cancer.

Authors:  P Peltomäki
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.

Authors:  Siu Tsan Yuen; Tsun Leung Chan; Judy W C Ho; Annie S Y Chan; Lap Ping Chung; Polly W Y Lam; Chun Wah Tse; Andrew H Wyllie; Suet Yi Leung
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

6.  Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients.

Authors:  J W Ho; S T Yuen; L P Chung; K Y Kwan; T L Chan; S Y Leung; A S Chan; C w Tse; P W Lam; I S Luk
Journal:  Int J Cancer       Date:  2000-07-20       Impact factor: 7.396

7.  A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing: a founder mutation in the Chinese population.

Authors:  T L Chan; S T Yuen; J W Ho; A S Chan; K Kwan; L P Chung; P W Lam; C W Tse; S Y Leung
Journal:  Oncogene       Date:  2001-05-24       Impact factor: 9.867

8.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Authors:  W D Foulkes; I Thiffault; S B Gruber; M Horwitz; N Hamel; C Lee; J Shia; A Markowitz; A Figer; E Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; J N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; A De La Chapelle; J Boyd; K Offit; G Rennert; G Chong; N A Ellis
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

9.  Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer.

Authors:  T L Chan; S T Yuen; L P Chung; J W Ho; K Y Kwan; A S Chan; J C Ho; S Y Leung; A H Wyllie
Journal:  J Natl Cancer Inst       Date:  1999-07-21       Impact factor: 13.506

10.  Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Authors:  Anja Wagner; Alicia Barrows; Juul Th Wijnen; Heleen van der Klift; Patrick F Franken; Paul Verkuijlen; Hidewaki Nakagawa; Marjan Geugien; Shantie Jaghmohan-Changur; Cor Breukel; Hanne Meijers-Heijboer; Hans Morreau; Marjo van Puijenbroek; John Burn; Stephany Coronel; Yulia Kinarski; Ross Okimoto; Patrice Watson; Jane F Lynch; Albert de la Chapelle; Henry T Lynch; Riccardo Fodde
Journal:  Am J Hum Genet       Date:  2003-03-25       Impact factor: 11.025

View more
  13 in total

1.  A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin.

Authors:  Iolanda Borelli; Marco A Barberis; Francesca Spina; Guido C Casalis Cavalchini; Caterina Vivanet; Luisa Balestrino; Monica Micheletti; Anna Allavena; Paola Sala; Carlo Carcassi; Barbara Pasini
Journal:  Eur J Hum Genet       Date:  2012-07-11       Impact factor: 4.246

2.  Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

Authors:  Patrizia Lastella; Margherita Patruno; Giovanna Forte; Alba Montanaro; Carmela Di Gregorio; Carlo Sabbà; Patrizia Suppressa; Adalgisa Piepoli; Anna Panza; Angelo Andriulli; Nicoletta Resta; Alessandro Stella
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

Review 3.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

5.  Hereditary Colorectal Cancer Syndromes in Hong Kong: a Registry's Perspective.

Authors:  Judy Wc Ho; Rockson Wei; Emily Ms Chan
Journal:  Hered Cancer Clin Pract       Date:  2005-10-15       Impact factor: 2.857

6.  An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.

Authors:  Yael Goldberg; Rinnat M Porat; Inbal Kedar; Chen Shochat; Daliah Galinsky; Tamar Hamburger; Ayala Hubert; Hana Strul; Revital Kariiv; Liat Ben-Avi; Moran Savion; Eli Pikarsky; Dvorah Abeliovich; Dani Bercovich; Israela Lerer; Tamar Peretz
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

7.  Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

Authors:  Christina Therkildsen; Anna Isinger-Ekstrand; Steen Ladelund; Anja Nissen; Eva Rambech; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

8.  Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Authors:  Hui-Ling Yap; Wei-Shieng Chieng; Jasmine Rui-Chen Lim; Robert Seng-Cheong Lim; Ross Soo; Jiayi Guo; Soo-Chin Lee
Journal:  Fam Cancer       Date:  2008-08-23       Impact factor: 2.375

9.  Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.

Authors:  Jose G Guillem; Emily Glogowski; Harvey G Moore; Khedoudja Nafa; Arnold J Markowitz; Jinru Shia; Kenneth Offit; Nathan A Ellis
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

10.  Detection of hMSH2 and hMLH1 mutations in Chinese hereditary non-polyposis colorectal cancer kindreds.

Authors:  Chang-Hua Zhang; Yu-Long He; Fang-Jin Wang; Wu Song; Xi-Yu Yuan; Dong-Jie Yang; Chuang-Qi Chen; Shi-Rong Cai; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.